Clinical data
Oral
Legal status
Identifiers
1-Cyclopropyl-7-[(3s,5r)-3,5-dimethylpiperazin-1-yl]-5,6,8-trifluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
PubChem CID
CompTox Dashboard (EPA)
Chemical and physical data
C19H20F3N3O3
395.382 g·mol−1
3D model (JSmol)
O=C(O)C1=CN(C2CC2)c3c(C1=O)c(F)c(F)c(c3F)N4C[C@H](C)N[C@H](C)C4
InChI=1S/C19H20F3N3O3/c1-8-5-24(6-9(2)23-8)17-14(21)13(20)12-16(15(17)22)25(10-3-4-10)7-11(18(12)26)19(27)28/h7-10,23H,3-6H2,1-2H3,(H,27,28)/t8-,9+ Y
Key:QIPQASLPWJVQMH-DTORHVGOSA-N Y
Orbifloxacin (brand name Orbax) is a fluoroquinolone antibiotic which is approved for use in dogs,[1][2] marketed by Schering-Plough Animal Health.
Antifolates
(inhibit bacterial
purine metabolism,
thereby inhibiting
DNA and RNA
synthesis)
Other/ungrouped
Combinations
Other DHPS inhibitors
Quinolones
(inhibit bacterial
topoisomerase
and/or DNA gyrase,
thereby inhibiting
DNA replication)
Newer non-fluorinated
Related (DG)
Nitroimidazole derivatives
RNA synthesis